Biohaven Awarded $4 Million Following Landmark Trade Secret Ruling—What Does This Mean for Investors?
Market Chameleon (Wed, 26-Aug 11:07 AM)
BHV-1300 Begins Phase 3: Biohaven’s Precision Immunology Approach Takes Aim at Root Cause of Graves’ Disease
Market Chameleon (Mon, 29-Jun 8:36 AM)
